Status:
UNKNOWN
Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis
Lead Sponsor:
Aswan University Hospital
Conditions:
Psoriasis
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The aim of the study is to evaluate the effect of NB-UVB versus MTX on serum Chitotriosidase level in psoriatic patients.
Eligibility Criteria
Inclusion
- Patients with moderate to severe plaque psoriasis of any age and gender.
Exclusion
- History of psoriasis treatment with systemic and biological agents prior to the study for at least 3 months.
- Pregnancy and lactation.
- Infections.
- Patients with chronic diseases: hepatic disorders, hematologic diseases, chronic renal failure or cancer.
Key Trial Info
Start Date :
January 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 15 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05427175
Start Date
January 10 2022
End Date
September 15 2023
Last Update
June 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University - Faculty of Medicine
Aswān, Aswan Governorate, Egypt, Egypt, 81528